Dimensional Fund Advisors LP Ocuphire Pharma, Inc. Transaction History

Dimensional Fund Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$2.04 - $3.53 $32 - $56	16 Added 0.06%	25,592 $90,000
Q3 2022 Nov 10, 2022	BUY	$1.82 - $2.79 $46,548 - $71,357	25,576 New	25,576 $51,000
Q2 2022 Aug 12, 2022	SELL	$1.8 - $3.25 $29,835 - $53,868	-16,575 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$3.4 - $5.19 $56,355 - $86,024	16,575 New	16,575 $62,000

2.58M

14.1K

800

Ticker OCUP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,579,800
Market Cap $20.2M
Description
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.